Clinical Trials Verified stories whose regulatory record supports clinical-trial access. Eligibility and enrollment are never guaranteed.
Filter clinical trials Filters Results 97 verified trial-access stories match your filters.
Important: Eligibility and enrollment are not guaranteed, and listing here is not a treatment recommendation. Talk to your care team.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT06623422
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Carcinoma, Non-Small-Cell Lung who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-28 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-28 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT06931717
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Non-Small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-28 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-28 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Multiple Myeloma
Trial identifier NCT04923893
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Multiple Myeloma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-25 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-25 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT05132075
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants ages 18 Years to 100 Years with Non-Small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-25 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-25 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lymphoma
Trial identifier NCT06091865
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Diffuse Large B-cell Lymphoma (DLBCL) who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-25 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-25 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Head and Neck Cancer
Trial identifier NCT06496178
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Head and Neck Squamous Cell Carcinoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-24 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-24 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT05215340
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Metastatic Non Small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-24 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-24 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT04400695
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants ages 18 Years to 70 Years with Breast Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-23 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-23 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT04989504
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Breast Carcinoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-23 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-23 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Endometrial (Uterine) Cancer
Trial identifier NCT05256225
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma who meet the study-specific registry eligibility criteria; sex eligibility: female.
Last reviewed 2026-09-22 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-22 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
CancerDiscoveries summarizes verified records in its database. Absence of a listing here does not establish that a treatment lacks regulatory authorization or access.